Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H10NO6P2.Na |
| Molecular Weight | 289.0947 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].OP(O)(=O)C(CC1=CC=CC=N1)P(O)([O-])=O
InChI
InChIKey=LZNFXJFOLTVFOP-UHFFFAOYSA-M
InChI=1S/C7H11NO6P2.Na/c9-15(10,11)7(16(12,13)14)5-6-3-1-2-4-8-6;/h1-4,7H,5H2,(H2,9,10,11)(H2,12,13,14);/q;+1/p-1
Piridronic acid is pyridinyl bisphosphonate. It is the bone calcium metabolism regulator. Piridronic acid was used for the treatment of osteoporosis. It is the human farnesyl pyrophosphate synthase inhibitor. When expressed on an actual or anticipated clinical dose basis for osteoporosis piridronic acid may have a greater potential for inducing gastric damage than do pyridinyl bisphosphonates. Piridronic acid induced significantly more antral damage than risedronate and a greater number of lesions compared to pamidronate and risedronate.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. | 2008-04-10 |
|
| Nonclinical model for assessing gastric effects of bisphosphonates. | 1997-02 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL99369
Created by
admin on Mon Mar 31 18:51:39 GMT 2025 , Edited by admin on Mon Mar 31 18:51:39 GMT 2025
|
PRIMARY | |||
|
Y-24
Created by
admin on Mon Mar 31 18:51:39 GMT 2025 , Edited by admin on Mon Mar 31 18:51:39 GMT 2025
|
PRIMARY | |||
|
C175191
Created by
admin on Mon Mar 31 18:51:39 GMT 2025 , Edited by admin on Mon Mar 31 18:51:39 GMT 2025
|
PRIMARY | |||
|
100188-33-8
Created by
admin on Mon Mar 31 18:51:39 GMT 2025 , Edited by admin on Mon Mar 31 18:51:39 GMT 2025
|
PRIMARY | |||
|
DTXSID40905247
Created by
admin on Mon Mar 31 18:51:39 GMT 2025 , Edited by admin on Mon Mar 31 18:51:39 GMT 2025
|
PRIMARY | |||
|
23700062
Created by
admin on Mon Mar 31 18:51:39 GMT 2025 , Edited by admin on Mon Mar 31 18:51:39 GMT 2025
|
PRIMARY | |||
|
300000055541
Created by
admin on Mon Mar 31 18:51:39 GMT 2025 , Edited by admin on Mon Mar 31 18:51:39 GMT 2025
|
PRIMARY | |||
|
C054229
Created by
admin on Mon Mar 31 18:51:39 GMT 2025 , Edited by admin on Mon Mar 31 18:51:39 GMT 2025
|
PRIMARY | |||
|
977W2XFR3R
Created by
admin on Mon Mar 31 18:51:39 GMT 2025 , Edited by admin on Mon Mar 31 18:51:39 GMT 2025
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD